Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs.

Autor: Jacob Søholm, Janne Fuglsang Hansen, Belinda Mössner, Birgit Thorup Røge, Alex Lauersen, Jesper Bach Hansen, Nina Weis, Toke Seierøe Barfod, Suzanne Lunding, Anne Øvrehus, Rajesh Mohey, Peter Thielsen, Peer Brehm Christensen

Publikováno v: PLoS ONE, Vol 15, Iss 12, p e0243725 (2020)

Background and aimsTo evaluate the ability of pretreatment liver stiffness measurements (pLSM) to predict hepatocellular carcinoma (HCC), incident decompensation and all-cause mortality in chronic hepatitis C (CHC) patients who achieved sustained vir

Externí odkaz: https://doaj.org/article/578a81fb836d444dad4a1943a01d9565

Ischemic Heart Disease in Chronic Hepatitis B:A Danish Nationwide Cohort Study

Autor: Frederik Faergemann Lau, Signe Bollerup, Frederik Engsig, Henrik Krarup, Lone Hagens Mygind, Jesper Bach Hansen, Lone Galmstrup Madsen, Peter Thielsen, Ulla Balslev, Lars Nørregaard Nielsen, Toke S Barfod, Mette Rye Clausen, Lise Hobolth, Alex Lund Laursen, Britta Tarp, Birgit T Roege, Jan Gerstoft, Peer Brehm Christensen, Nina Weis

Publikováno v: Lau, F F, Bollerup, S, Engsig, F, Krarup, H, Mygind, L H, Hansen, J B, Madsen, L G, Thielsen, P, Balslev, U, Nielsen, L N, Barfod, T S, Clausen, M R, Hobolth, L, Laursen, A L, Tarp, B, Roege, B T, Gerstoft, J, Christensen, P B & Weis, N 2022, ' Ischemic Heart Disease in Chronic Hepatitis B : A Danish Nationwide Cohort Study ', Clinical epidemiology, vol. 14, pp. 879-888 . https://doi.org/10.2147/CLEP.S361910
Lau, F F, Bollerup, S, Engsig, F, Krarup, H, Mygind, L H, Hansen, J B, Madsen, L G, Thielsen, P, Balslev, U, Nielsen, L N, Barfod, T S, Clausen, M R, Hobolth, L, Laursen, A L, Tarp, B, Roege, B T, Gerstoft, J, Christensen, P B & Weis, N 2022, ' Ischemic Heart Disease in Chronic Hepatitis B : A Danish Nationwide Cohort Study ', Clinical Epidemiology, vol. 14, pp. 879-888 . https://doi.org/10.2147/CLEP.S361910
Lau, F F, Bollerup, S, Engsig, F, Krarup, H, Mygind, L H, Hansen, J B, Madsen, L G, Thielsen, P, Balslev, U, Nielsen, L N, Barfod, T S, Clausen, M R, Hobolth, L, Laursen, A L, Tarp, B, Roege, B T, Gerstoft, J, Christensen, P B & Weis, N 2022, ' Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study ', Clinical Epidemiology, vol. 14, pp. 879-888 . https://doi.org/10.2147/CLEP.S361910

Frederik Faergemann Lau,1 Signe Bollerup,1 Frederik Engsig,1 Henrik Krarup,2 Lone Hagens Mygind,3 Jesper Bach Hansen,3 Lone Galmstrup Madsen,4,5 Peter Thielsen,6 Ulla Balslev,7 Lars Nørregaard Nielsen,8 Toke S Barfod,9 Mette Rye Clausen,10 Lise Ho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bdcbe3be937519db118f059ac2c7ba4
https://pure.au.dk/portal/da/publications/ischemic-heart-disease-in-chronic-hepatitis-b(686ed88a-dd67-4787-b7b2-959fe494af7f).html

Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs

Autor: Birgit Røge, Belinda Klemmensen Mössner, Jacob Søholm, Nina Weis, Janne Fuglsang Hansen, Toke S Barfod, Suzanne Lunding, Peer Brehm Christensen, Jesper Bach Hansen, Anne Øvrehus, Alex Lauersen, Peter Thielsen, Rajesh Mohey

Publikováno v: Søholm, J, Hansen, J F, Mössner, B, Røge, B T, Lauersen, A, Hansen, J B, Weis, N, Barfod, T S, Lunding, S, Øvrehus, A, Mohey, R, Thielsen, P & Christensen, P B 2020, ' Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs ', PLoS ONE, vol. 15, no. 12 December, e0243725 . https://doi.org/10.1371/journal.pone.0243725
PLoS ONE, Vol 15, Iss 12, p e0243725 (2020)
Søholm, J, Hansen, J F, Mössner, B, Røge, B T, Lauersen, A, Hansen, J B, Weis, N, Barfod, T S, Lunding, S, Øvrehus, A, Mohey, R, Thielsen, P & Christensen, P B 2020, ' Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs ', PLOS ONE, vol. 15, no. 12, e0243725 . https://doi.org/10.1371/journal.pone.0243725
PLoS ONE
Søholm, J, Hansen, J F, Mössner, B, Røge, B T, Lauersen, A, Hansen, J B, Weis, N, Barfod, T S, Lunding, S, Øvrehus, A, Mohey, R, Thielsen, P & Christensen, P B 2020, ' Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs ', PLOS ONE, vol. 15, no. 12 December, e0243725 . https://doi.org/10.1371/journal.pone.0243725

Background and aims To evaluate the ability of pretreatment liver stiffness measurements (pLSM) to predict hepatocellular carcinoma (HCC), incident decompensation and all-cause mortality in chronic hepatitis C (CHC) patients who achieved sustained vi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3db6e10954a8a03aa77c1566fb4a23c
https://curis.ku.dk/portal/da/publications/low-incidence-of-hcc-in-chronic-hepatitis-c-patients-with-pretreatment-liver-stiffness-measurements-below-175-kilopascal-who-achieve-svr-following-daas(943ef18d-b7dd-4a4e-a3c0-60c5cbc9b14f).html

High sustained virologic response rates in patients with chronic hepatitis C virus GT1, 2 or 3 infection following 16 weeks of MK-3682/grazoprevir/ruzasvir plus ribavirin after having failed 8 weeks of a triplet drug regimen (Part C of C-CREST-1 & 2)

Autor: Janice Wahl, S. Jin, N. Gendrano, Frank J. Dutko, H.-C. Huang, E.J. Gane, H. Liu, M. Su, Eliav Barr, R. Plank, Jesper Bach Hansen, Ziv Ben Ari, Alex Lund Laursen, J. Bourque, S. Pianko, Bach-Yen Nguyen, Joan R. Butterton, A. Grandhi, Lawrence Serfaty, D. Fernsler, Wendy W. Yeh

Publikováno v: Serfaty, L, Pianko, S, Ben Ari, Z, Laursen, A L, Hansen, J B, Gane, E J, Huang, H C, Jin, S, Bourque, J, Liu, H, Grandhi, A, Su, M, Gendrano, N, Fernsler, D, Dutko, F, Nguyen, B Y T, Wahl, J, Barr, E, Yeh, W, Plank, R & Butterton, J R 2017, ' High sustained virologic response rates in patients with chronic hepatitis C virus GT1, 2 or 3 infection following 16 weeks of MK-3682/grazoprevir/ruzasvir plus ribavirin after having failed 8 weeks of a triplet drug regimen (Part C of C-CREST-1 & 2) ', Journal of Hepatology, vol. 66, no. 1, THU-264, pp. S306-S307 . https://doi.org/10.1016/S0168-8278(17)30931-5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16af9aa59068d74152dd9f0bbfeeb544
https://vbn.aau.dk/da/publications/d84eec5d-ca88-4ee9-920d-98fa12a2d61e

Spectral and dynamic electroencephalogram abnormalities are correlated to psychometric test performance in hepatic encephalopathy

Autor: Carina Graversen, Søren Schou Olesen, Kristoffer Steimle, Jesper Bach Hansen, Tine Maria Hansen, Asbjørn Mohr Drewes, Rolf Ankerlund Blauenfeldt

Publikováno v: Olesen, S S, Gravesen, C, Hansen, T M, Blauenfeldt, R, Hansen, J B, Lindegaard Steimle, K & Drewes, A M 2011, ' Spectral and dynamic electroencephalogram abnormalities are correlated to psychometric test performance in hepatic encephalopathy ', Scandinavian Journal of Gastroenterology, vol. 46, no. 7-8, pp. 988-96 . https://doi.org/10.3109/00365521.2011.579160
Olesen, S S, Graversen, C, Hansen, T M, Blauenfeldt, R A, Hansen, J B, Steimle, K & Drewes, A M 2011, ' Spectral and dynamic electroencephalogram abnormalities are correlated to psychometric test performance in hepatic encephalopathy ', Scandinavian Journal of Gastroenterology, vol. 46, no. 7-8, pp. 988-996 . https://doi.org/10.3109/00365521.2011.579160

Objective. Alterations of the electroencephalogram (EEG) have been reported in patients with hepatic encephalopathy (HE). However, previous methods have not assessed transient phenomena in the EEG signal (dynamics) and associations to psychometric te

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e1af578d3a9c37ea050d74719aa6e35
https://doi.org/10.3109/00365521.2011.579160